United States flu vaccine Market Report by Price Trade, Market Trade, Import and Export, Growth, Supply and Demand Forecast 2017-2022.

(Medical-NewsWire.com, October 08, 2018 ) United States flu vaccine market is expected to reach nearly US$ 3 Billion by 2024. Growth in US flu vaccine market can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against flu vaccine and introduction of quadrivalent flu vaccine.

Get Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/HnM/QBI-DPI-HnM-3136

Long–term Growth Projection and Development:

• Sanofi to Acquire Protein Sciences Corporation
• It is likely that more than 185 Million persons being vaccinated with flu vaccines in 2024.
• Nearly 160 Million doses of flu vaccines have shipped to US for the 2017-2018 flu season
• It is projected that GSK flu vaccine sales value will reach around US$ 1.5 Billion by 2024
• BiondVax reports positive phase 2b clinical trial results for its universal flu vaccine

The report concludes with the profiles of major players in the US flu vaccine market such as Sanofi Pasteur, GSK and Seqirus. The major market players are evaluated on various parameters such as company overview, product outlook, latest development & trends and sales analysis of flu vaccine market from 2011 to 2022. The report also entails major drivers and inhibitors in the US flu vaccine market.

Purchase Report@ https://www.qurateresearch.com/report/buy/HnM/QBI-DPI-HnM-3136/ (Priced at USD 1150)
“Flu Vaccine Market Outlook 2024: United States Opportunity and Demand Analysis, Market Forecast 2017-2024” provides a deep and thorough evaluation of the United States flu vaccine market. The report provides an in–depth analysis of the flu vaccination pattern in both Children and Adults in the United States. It also provides essential insights into flu vaccine production, price, consumption, supply, distribution, demand and specification. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials and promising flu vaccines in the clinical development. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details.

Key Topics Covered in the Report
• Market Overview: United States Flu Vaccine Market (2010 - 2024)
• United States Number of Persons Vaccinated with Flu Vaccine (2010 - 2024)
• United States Flu Vaccine Production, Price, Consumption, Supply, Distribution, Demand and Specification
• Reimbursement & Regulatory System in the US Flu Vaccine Market
• Mergers, Acquisitions, Key Agreements & Collaborations
• Promising Flu Vaccine in Clinical Development
• Flu Vaccine Clinical Trial Insights by Phase, Company & Country
• Key Drivers and Inhibitors of the US Flu Vaccine Market
• Key Companies Analysis

Major Flu Vaccines Covered Under This Report Are:

• Fluzone High–Dose
• Fluzone Quadrivalent
• Intradermal (ID) Trivalent
• Vaxigrip
• Fluarix Quadrivalent
• Flulaval Quadrivalent
• Flucelvax Quadrivalent
• Afluria Quadrivalent
• Agrippal
• Fluad
• Fluvirin
• Fluvax

Enquiry about Report@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-DPI-HnM-3136

Table of Content:

1. Executive Summary
2. Market Overview: United States Flu Vaccine Market (2010 - 2024)
3. United States Number of Persons Vaccinated with Flu Vaccine (2010 - 2024)
3.1 Number of Children Vaccinated
3.2 Number of Adults Vaccinated
4. Key Drivers and Inhibitors of the United States Flu Vaccine Market
4.1 Market Drivers
4.2 Market Inhibitors
5. United States Flu Vaccine Production, Price, Consumption, Supply, Distribution, Demand and Specification
5.1 Flu Vaccine Price Trends
6. United States Flu Vaccine Market – Reimbursement & Regulatory System
6.1 Reimbursement System
6.2 Regulation System
7. Market Dynamics – Mergers, Acquisitions, Key Agreements & Collaborations
7.1 Merger & Acquisitions
7.2 Collaboration Deal
7.3 Licensing, Exclusive & Distribution Agreement Deal
8. Flu Vaccine – Promising Vaccine in Clinical Development
8.1 Quadrivalent Seasonal Influenza VLP Vaccine
9. Flu Vaccine – Clinical Trial Insights by Phase, Company & Country
9.1 Year 2017
9.2 Year 2016
10. Key Companies Analysis

Enquiry for Customization@ https://www.qurateresearch.com/report/customize/HnM/QBI-DPI-HnM-3136

List of figures: List of Tables

Table 5–2: United States – Pediatric Flu Vaccine Price, 2017 – 2018
Table 5–3: United States – Adult Flu Vaccine Price, 2017 – 2018
Table 5–4: United States – Flu Vaccine Production, Supply, and Allocation
Table 5–5: Total Percentage of Flu Vaccines Released by Week,2016 – 2017
Table 5–6: Total Percentage of Flu Vaccines Released by Week,2015 – 2016

Qurate Business Intelligence

Nehal Chinoy

+919881074592

nehal@qurateresearch.com

Source: EmailWire.Com

Source: EmailWire.com

Medical Newswire!

United States flu vaccine Market Report by Price Trade, Market Trade, Import and Export, Growth, Supply and Demand Forecast 2017-2022.